Table 2

Baseline patient sociodemographic and clinical information of the intervention and control groups (mean and range unless otherwise stated)

InterventionControl
Sociodemographic profile
 Number9580
 Age (years)66 (39–82)62 (42–87)
 Male (%)50 (52%)46 (57%)
 Duration of education (years) (SD)12.22 (4.83) (8–45*)11.49 (2.74) (2–22)
 Ethnicity white (%)85 (89.5%)71 (88.8%)
Clinical profile
 Duration of diabetes (years) (SD)8.4 (4.1) (1–25)7.07 (3.83) (1–16)
 HbA1c (IFCC HbA1c mmol/mol) in past 12 months (%) (SD)8.6 {70} (1.9)8.8 {73} (0.98)
(7.4–13.1) {57–120}(7.5–11.5) {58–102}
Number with diabetic complications (%)
 Coronary heart disease29/93 (31.1)13/80 (16.2)
 Peripheral vascular disease3/93 (3.22)3/80 (3.75)
 Stroke8/93 (8.6)5/80 (6.25)
 Retinopathy20/93 (21.5)10/80 (12.5)
 Nephropathy5/93 (5.37)10/80 (12.5)
 Neuropathy5/93 (5.37)3/80 (3.75)
Number with comorbidities (%)
 Hypertension58/93 (62.3)43/80 (53.75)
 Dyslipidaemia52/93 (55.9)38/80 (47.5)
Health service utilisation
Number of diabetes-related visits to the general practice in the past 6 months (SD)
 General practitioners0.92 (1.13) (0–5)1.41 (1.68) (0–11)
 Nurse2.15 (1.84)1.89 (1.36)
 Number of diabetes-related visits to the hospital in the past 6 months (SD)0.51 (0.87)0.45 (0.67)
 Length of consultation (min)15.31 (2–39)16.95 (5–45)
  • *Self-report (this figure includes self-taught continuing education outwith a formal educational programme).